TWST Twist Bioscience: Company Current Liabilities

Twist Bioscience Inc (TWST) - corporate logo

The market value dynamics of Twist Bioscience (TWST), where the indicator stands at 0.01, correlate with a silicon-substrate gene synthesis model featuring minimal dependence on external suppliers. The business relies on laboratory demand for synthetic chains and progress in bio-digital data storage. Growth is driven by the implementation of AI-managed automated microprinting systems for high-precision manufacturing.

Twist Bioscience, Inc. - TWST Short-Term Debt Volume (period 07/04/2022 - 10/29/2026)

TWST (Twist Bioscience Corp): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Quotes Twist Bioscience, Inc.|TWST - Analyst Forecast Prices
- market capitalization data:
Market Valuation Twist Bioscience, Inc.|TWST - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Twist Bioscience|TWST - Book Valuation of Business|Market Value to Book Value Ratio twistbioscience.com|TWST - Company Total Asset Base
- debt and liquidity data:
Total Debt to Equity Ratio Twist Bioscience|TWST - Long-Term Loans to Capital Ratio|Short-Term Debt to Equity Ratio Twist Bioscience|TWST - Aggregate Debt Obligations|Debts to Book Capitalization Twist Bioscience, Inc.|TWST - Company Long-Term Debt|Company Short-Term Debts Twist Bioscience
Analysis of all company metrics:TWST - Twist Bioscience, Inc.
Original product of twistbioscience.com

Short-term debt represents the aggregate of all financial obligations of Twist Bioscience (TWST) with a maturity of less than twelve months. By analyzing the short-term debt chart, an investor assesses current liquidity and the company's ability to service its loans. This metric measures pressure on working capital, given the sensitivity to loan repayment rates. Stable management of these liabilities is critical to ensuring seamless synthetic DNA logistics and the prompt delivery of biomaterials. Balancing these risks requires comparing this burden with revenue dynamics.

Competitors of Twist Bioscience (TWST)

Company Current Liabilities Tempus AI, Inc TEM|Qiagen NV (QGEN) - Amount of Current Liabilities|IONS (Ionis Pharma) - Company Current Liabilities|Repligen Inc. (RGEN) - Company Current Liabilities|RNA: Company Short-Term Debts|Short-Term Debt Volume CRSP|WGS (GeneDx) - Company Short-Term Debt|Short-Term Debt Volume Ultragenyx Pharmaceutical Inc. RARE|Company Current Liabilities Beam Therapeutics Corp (BEAM)|SRPT - Amount of Current Liabilities|Company Current Liabilities 10x Genomics, Inc. (TXG)|NTLA - Company Short-Term Loans and Borrowings|Stoke Therapeutics, Inc. (STOK) - Company Short-Term Debts|BioLife Solutions Inc (BLFS) - Company Short-Term Debt|WVE: Company Short-Term Debts|Short-Term Debt Volume MAZE|Sionna Therapeutics Inc - Company Short-Term Debt|Short-Term Debt PRME (primemedicine.com)|Company Short-Term Debt TSHA|Short-Term Debt Volume uniQure NV QURE|MGTX: Company Short-Term Debts|RGNX - Company Current Liabilities|Solid Biosciences Inc. - Company Short-Term Debts|ocugen.com (OCGN) - Short-Term Debt Volume|Company Short-Term Debts PACB (PacBio)|Short-Term Debt BNTC|Company Short-Term Debt Design Pharma DSGN|Company Short-Term Indebtedness Rocket Corp (RCKT)|4D Molecular Therapeutics - Company Short-Term Debts|Company Current Liabilities Lexeo Therapeutics Inc. LXEO|KRRO (Korro Bio, Inc) - Company Short-Term Debts|Editas Medicine Inc (EDIT) - Short-Term Debt|SLN - Company Current Liabilities|Amount of Current Liabilities ProQR Therapeutics|Company Current Liabilities CDXS|Company Current Liabilities SGMO|NAUT (Nautilus Biotechnology) - Company Short-Term Debt|Short-Term Debt Volume Metagenomi Inc. MGX|Company Current Liabilities Precision BioSciences (DTIL)|Amount of Current Liabilities Generation Bio Co GBIO|Boundless Bio, Inc. (BOLD) - Company Short-Term Debts|XCUR: Company Short-Term Indebtedness|Company Short-Term Debt imunon.com|Phio Pharmaceuticals Corp. (PHIO) - Company Short-Term Indebtedness|MBIO (Mustang Bio Inc) - Company Short-Term Debts|Company Short-Term Debts TransCode (RNAZ)|Company Current Liabilities Bionano Genomics, Inc.|Amount of Current Liabilities adnas.com APDN|bluebird bio - Company Current Liabilities|Company Current Liabilities ImmunoPrecise Antibodies Ltd IPA|Company Short-Term Debts OMGA (Omega)|OMIC: Short-Term Debt Volume|Regulus Therapeutics - Company Short-Term Debt|Short-Term Debt Volume syros.com|Telesis Bio (TBIO) - Company Current Liabilities|Amount of Current Liabilities TRACON Pharmaceuticals Inc. (TCON)|Unity Bio (UBX) - Company Current Liabilities